Winpe launches ‘Women on Boards' programme to strengthen gender diversity in PE-VC boardrooms
NEW DELHI:
Winpe
, a gender diversity-focused non-profit organisation, announced the launch of its 'Women on Boards' programme. This initiative aims to address the persistent underrepresentation of women on corporate boards across India. The programme focuses on creating a pipeline of board-ready women professionals and connecting them with private equity and venture capital-backed companies.
The initiative will focus on increasing both the demand and supply of women directors. To address the demand side, Winpe has secured commitments from its member base of global and regional PE-VC firms and their portfolio companies to prioritise diverse boards. These firms understand the value diverse perspectives bring to boardroom discussions and are keen to actively seek out and appoint qualified women to the boards of their portfolio companies. On the supply side, Winpe is focused on identifying and nurturing women who are ready to take on board roles. It will build a database of senior women professionals, including those with experience as entrepreneurs, advisors, and senior functional leaders. Key components include a board of advisors, training for first-time directors, a screening committee, and a panel of mentors. In addition, Winpe will organise knowledge sessions and facilitate peer groups and connections amongst women who are on corporate boards.
According to a 2023 EY report, as of 2022, women held just 18% of board seats in India, and nearly 600 companies have only one woman on their boards.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
New mobile air conditioner requires no installation (search now)
Air Condition | Search Ads
Search Now
Undo
Nupur Garg, Founder, Winpe, said in a statement, 'We believe that by building a strong ecosystem to support both companies seeking diverse board members and women ready to lead, we can drive better governance and economic growth. While regulatory requirements have moved the needle, the numbers are far from satisfactory. One woman on a board of seven is not enough, real diversity starts when women hold multiple or equal seats at the table and are included for their experience, knowledge and leadership, not just for legal reasons.
Winpe has received support from
British International Investment
(BII), the UK's development finance institution and impact investor, to develop the Winpe
Women on Boards
programme. This programme builds on the key findings of BII's report 'How do companies and funds with female owners and leaders support positive outcomes for women?'. It shows that gender-diverse-led businesses are more likely to implement more diverse and inclusive workplaces. BII's support will enable Winpe to scale its efforts and expand the reach and impact of the programme.
Live Events
Shilpa Kumar, Managing Director and Head of India, British International Investment, said in a statement, 'In India, supporting women in accessing board opportunities is not just about representation; it is about strengthening the foundations of governance, decision-making, and long-term value creation. Our partnership with Winpe reflects our commitment to enabling systemic change by supporting platforms that address structural barriers and unlock leadership opportunities for women across the private equity and
venture capital
ecosystem,' said .
The Board of Advisors for the 'Women on Boards' initiative comprises professionals: Deepak Kapoor, Former Chairman and CEO, PwC India; M Damodaran, Chairperson, Excellence Enablers, and Ex-Chairman, SEBI; Naina Lal Kidwai, Former Chairperson, HSBC Group, and Padma Shri Awardee; and Zia Mody, Co-Founder and Managing Partner, AZB & Partners.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
38 minutes ago
- Time of India
StarBigBloc Building gets shareholders' nod for IPO
StarBigBloc Building Material, a wholly-owned subsidiary of BigBloc Construction , on Tuesday said it has received shareholders' approval to raise funds through an initial public offering. The Initial Public Offering plan, cleared at an extraordinary general meeting held on June 13, is aimed at unlocking value, raising growth capital for expansion, and enhancing the valuation of the parent company BigBloc Construction , it said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo The public issue proposal is subject to necessary regulatory approvals, prevailing market conditions, and other applicable clearances, it added. "The IPO will enable StarBigBloc Building Material to access capital markets, drive the next phase of expansion, and solidify its market position across India," Mohit Saboo, Director and Chief Financial Officer of BigBloc Construction, said. Incorporated in 2015, BigBloc Construction is one of the largest and only listed AAC block manufacturers in India, with a 1.3 million cubic meters annual capacity across plants in Gujarat and Maharashtra. For FY25, BigBloc Construction reported revenue from operations of Rs 224.6 crore. Live Events StarBigBloc Building Material operates a manufacturing facility in Gujarat with an installed capacity of 2.5 lakh cubic meters per annum. In May 2024, StarBigBloc board approved a proposal to raise funds through an SME IPO or preferential issue. As part of its long-term growth roadmap, StarBigBloc aims to increase its production capacity from the current 2.5 lakh cubic meters per annum to over 1.2 million cubic meters per annum over the next 4-5 years. The company is also targeting revenues of Rs 428 crore by FY28, with an estimated net profit of Rs 80 crore.
Time of India
38 minutes ago
- Time of India
Pharma stocks fall up to 4% after Trump says pharma tariffs coming very soon
Pharma stocks fell up to 4% on Tuesday, June 17, after U.S. President Donald Trump today said that pharma tariffs are coming very soon. Following the update, Aurobindo Pharma fell 4% to Rs 1,094.4, while Lupin , Granules, and Natco Pharma dropped 3–4%. Laurus Labs , Dr. Reddy's, Sun Pharma , and Glenmark Pharma also slipped 2–3%. Meanwhile, the Nifty Pharma index slipped 2.2%, with 19 out of 20 constituent stocks trading in the red. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Building Automation Systems Software Cost Might Surprise you Automation Systems | Search Ads Undo In April, Trump hinted at imposing 'major' tariffs on imported medicines to push drugmakers to shift manufacturing to the U.S., citing national security concerns under Section 232 powers. 'We don't make pharmaceuticals anymore… We'll be announcing pharmaceuticals at some point in the not-too-distant future,' he said earlier. Also Read: Street favourites! Analysts see these 10 smallcap stocks rallying 20-80% Indian drugmakers could face impact India, one of the largest suppliers of medicines to the U.S., could be significantly affected if Trump announces new tariffs on pharma imports. In 2024, India's pharmaceutical exports were valued at USD 12.72 billion, making it the country's largest industrial export sector. Live Events Indian pharmaceutical companies play a crucial role in the U.S. healthcare system. In 2022, they accounted for four out of every ten prescriptions filled in the U.S. According to reports, medicines from Indian firms saved the U.S. healthcare system USD 219 billion in 2022 alone, and USD 1.3 trillion between 2013 and 2022. Over the next five years, generics from India are projected to deliver an additional USD 1.3 trillion in savings. Also Read: 6 IPOs set to open this week. Check latest GMP trends Experts have warned that imposing higher tariffs on pharmaceutical imports could severely hurt Indian drug manufacturers by raising production costs and eroding their price competitiveness compared to rivals from other countries.
Time of India
an hour ago
- Time of India
Explained: Why Qatar Airways cancelled its Major Boeing order and returned to Airbus
Up: Boeing 737 MAX 10/ Down: Qatar Airways A321neo/ Photo: Qatar Airways, Boeing In late May 2025, Qatar Airways made the strategic decision to cancel its order for 25 Boeing 737 MAX 10s, a move confirmed by CEO Badr Mohammed Al Meer in an interview with Bloomberg. a move that not only ends its short-lived venture into the type but also reshapes the airline's entire narrowbody strategy. The order, which also included options for 25 more, was placed during the 2022 Farnborough Airshow, a time when the airline's relationship with Airbus was at an all-time low, the deal was positioned as a solution for the airline's regional network, with Boeing Commercial Airplanes' then-CEO Stan Deal praising the aircraft as "ideally suited for Qatar Airways' regional network." But two years later, delays in the 737 MAX 10's certification, which has pushed its expected entry into commercial service to 2026 at the earliest, have forced the airline to reconsider. Qatar Airways is not alone in facing these setbacks, major carriers like United Airlines, American Airlines, and Delta Air Lines are also waiting, with growing frustration. In fact, United's Chief Commercial Officer, Andrew Nocella, told Reuters that the 737 MAX 10 isn't expected to arrive before 2027 or even 2028, and the airline is now hesitant to convert any MAX 9 orders into MAX 10s. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like เทรดทองCFDs ด้วยค่าสเปรดที่ต่ำที่สุด IC Markets สมัคร Undo 'We want to see the aircraft certified before we make the firm commitment,' Nocella said. Qatar Airways, meanwhile, opted to walk away entirely. A Falling Out, and Reconciliation With Airbus Qatar's move to order the 737 MAX 10s in 2022 wasn't born purely of performance metrics, it was a response to an escalating legal and commercial dispute with Airbus. That year, Qatar Airways grounded all 29 of its Airbus A350s, citing what it described as "accelerated surface degradation" of the aircraft's painted fuselage. In response, the airline filed a lawsuit seeking $600 million in damages from Airbus and publicly challenged the safety and airworthiness of the A350 fleet. Airbus, while acknowledging cosmetic and surface issues, insisted the aircraft were structurally safe and continued deliveries to other customers. During this high-profile conflict: Qatar Airways cancelled its remaining order for 23 Airbus A350s. The airline also cancelled a separate order for 50 Airbus A321neos, a fleet critical to its short-haul operations. At the peak of the fallout, the Boeing 737 MAX 10 was pulled in to fill that gap, offering Qatar Airways an alternative narrowbody solution as it severed ties, temporarily, with Airbus. But in early 2023, the feud reached a resolution. Both parties issued a joint statement announcing that the matter had been settled amicably: "Qatar Airways and Airbus are pleased to have reached an amicable and mutually agreeable settlement in relation to their legal dispute over A350 surface degradation and the grounding of A350 aircraft. A repair project is now underway and both parties look forward to getting these aircraft safely back in the air." Following this, Qatar reinstated the order for 50 A321neos, and Airbus resumed delivery plans for the grounded A350s. The settlement not only restored fleet development plans but reset the tone of the Qatar-Airbus relationship. Why Airbus Is Back In, And Boeing Narrowbodies Are Out Qatar Airways' Chief Executive Officer Badr Mohammed Al Meer, in an interview with Bloomberg , confirmed the airline had dropped the MAX 10 order, which also included options for 25 more aircraft. This decision, he revealed, was made in conjunction with a massive new Boeing widebody order that dwarfs the value of the narrowbody deal. Earlier this month, Qatar Airways placed its largest-ever aircraft order, agreeing to purchase 130 Boeing 787 Dreamliners and 30 Boeing 777-9s, with options for an additional 50 aircraft, a potential total of 210 widebodies valued at $96 billion. Responding to whether the airline was playing Boeing and Airbus against each other, Al Meer told Bloomberg's Francine Lacqua: 'You know, for the time being, we need to focus on finalizing our agreement with Boeing. As you saw, we are not like other airlines where we split our orders 20 today, 20 next year. Because we are basing our order on a very solid strategy and we decided to go with the 210 aircraft order. However, it doesn't mean that Airbus is out of the game. Our narrowbodies will continue to be Airbus.' In a separate public comment, Al Meer reiterated the airline's direction: 'Our narrowbody [fleet] will continue to be Airbus. We are receiving 50 A321neos starting next year. So our whole narrowbody fleet will be basically operated by Airbus. We continue to receive A350-1000s, and there will always be a chance for another order from Airbus.' What Qatar Airways' Fleet Looks Like Now, And What's Coming As of now, Qatar Airways operates a limited narrowbody fleet consisting of: Current Narrowbody Fleet 27 Airbus A320s Two configurations: Version 1: 12 Business + 120 Economy = 132 seats Version 2: 12 Business + 132 Economy = 144 seats 3 Boeing 737 MAX 8s 8 Business + 168 Economy = 176 seats Several MAX 8s previously operated by Qatar Airways have already been leased to IndiGo for routes between Qatar and India. The remaining three are expected to be phased out soon, aligning with the airline's plan to standardize its narrowbody fleet around Airbus. Airbus Orders in Pipeline 40 Airbus A321neos 10 Airbus A321LRs Deliveries begin in 2026 Current and Future Widebody Fleet Aircraft Type In Fleet On Order Airbus A350-1000 24 18 Boeing 787 41 130 Boeing 777X 0 90 Qatar Airways is already the largest operator of the Airbus A350-1000 globally. The aircraft typically features two configurations: 24 Business + 371 Economy = 395 passengers 46 Business + 182 Economy = Premium-heavy layout In the years ahead, the airline will boast one of the most modern widebody fleets in the world, operating from its hub at Doha Hamad International Airport (DOH). What's Next? More Airbus Orders May Follow While Boeing has secured a record-breaking widebody order, there's speculation that Qatar Airways may also return to Airbus for additional widebodies. Possibilities include: More A350s, to complement the airline's current dominance in that model. Airbus A330-900s, a potential replacement for its aging A330-200s and A330-300s. Qatar Airways' renewed ties with Airbus open the door for future deals, as the airline looks to refine and expand its fleet under a disciplined, long-term strategy. The airline is clearly not chasing diversification for its own sake, it's targeting operational efficiency, flexibility, and strategic alignment with its growth ambitions. As for Boeing, with a growing backlog of 737 MAX 10 orders, the manufacturer now faces intensifying pressure to resolve regulatory hurdles that have kept the aircraft grounded in the certification process. The delays are prompting several major carriers to reconsider their long-term fleet strategies. Qatar Airways is not alone in stepping back from the MAX 10; United Airlines, one of the aircraft's largest customers, has expressed deep concerns over delivery timelines. American Airlines, Delta Air Lines, and Alaska Airlines, all with MAX 10 orders in the pipeline, are also closely watching the certification timeline, with some reportedly exploring alternative options or reconfiguring existing commitments.
